Yu Wang

15PUBLICATIONS
9CO-AUTHORS
Molecular targetsCancer cell biologyCancer diagnosisHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 29, 2026
Targeting EZH2-driven cholesterol metabolic vulnerability through Napabucasin suppresses ovarian cancer metastasis.

|Feb 27, 2026
CRISP3, a Potential Tumor Suppressor, Inhibits the Progression of High-Grade Serous Ovarian Carcinoma by Modulating the PI3K/AKT Pathway.

Mingjun Ma, Xiu Tian, Weiwei Cao

|Feb 27, 2026
Decoding AI Competence: Benchmarking Large Language Models (LLMs) in Ovarian Cancer Diagnosis and Treatment-A Systematic Evaluation of Generative AI Accuracy and Completeness.

Haojie Cai, Chao Wang, Yue Zhang

|Jul 09, 2025
Targeting CDK9 With Harmine Induces Homologous Recombination Deficiency and Synergizes With PARP Inhibitors in Ovarian Cancer.

Hao Zhang, Xiaomei Luo, Shiwei Li

|Dec 28, 2024
A Neutrophil Extracellular Traps-Related Signature Predicts Clinical Outcomes and Identifies Immune Landscape in Ovarian Cancer.

Yue Zhang, Chao Wang, Shanshan Cheng

|Apr 18, 2024
Boosted photo-immunotherapy via near-infrared light excited phototherapy in tumor sites and photo-activation in sentinel lymph nodes.

Chen Wang, Bobo Gu, Shuhong Qi

Pageof 3

Frequent Collaborators

4 joint publications

Haojie Cai

3 joint publications

Shanshan Cheng

2 joint publications

Yaqian Zhao

2 joint publications

Renhao Xue